Global Liver Institute
News
GLOBAL LIVER INSTITUTE
Six Tips to Help Your Patients through Organ Transplantation
Dr. Alin Gragossian is a physician trained in both emergency medicine and critical care medicine at Equum Medical. Beyond her clinical roles, she serves as an associate medical director at Donor Network West, a nonprofit, organ procurement and tissue recovery organization serving Nevada and California. Notably, Dr. Gragossian brings a unique perspective to her work, having undergone a heart transplant in 2019 at the age of 30.
Congress passes Continuing Resolution to extend federal funding into March 2024
Congress has again averted a government shutdown through the passage of a Continuing Resolution (CR) for funding the government into early March 2024. Election year politics make bipartisanship essential to advancing key legislation in the House and Senate. The current administration will be looking to finalize program regulations and advance key administration priorities before the elections.
GLI VP Raises NASH Awareness in the Managed Care Community – NASH News
Jeff McIntyre Raises NASH Awareness Among Health Care Community, Fatty Liver Disease More Fatal for Women, and more!
It’s Rare Liver Diseases Month! – Pediatric & Rare Liver Diseases News
It’s Rare Liver Diseases Month!
If you haven’t already, join us for the 2024 #RareAware multifaceted campaign, focusing on the theme of “Transitions in Care During.”
Using Microscopic Bubbles to Blast Cancer & More
New Technique Uses Microscopic Bubbles to Blast Cancer, Liver Cancer Rates Increase In Mexican Americans, and more!
For Rare Liver Disease Patients, Care Transitions Pose Yet Another Risk
(Washington D.C., February 1, 2023) – Today marks the start of Global Liver Institute’s (GLI) 2024 #RareAware campaign, which calls attention to the more than 100 rare liver diseases throughout February, Rare Liver Diseases Month. Drawing upon insights from patients, caregivers, advocacy groups, clinicians, and other interested parties, the campaign addresses the challenges that transpire when someone with a rare liver disease encounters a transition – whether from pediatric to adult care, from pre- to post-transplant, from inpatient to outpatient care, or another transition.
Hope for Early Detection & Treatment – Liver Cancer News
🎉Happy New Year! 🎉 We hope you had time to rest and refresh.
As we step into 2024, we’re excited to continue to bring the latest information and tackle the challenges and opportunities that lie ahead in the liver cancers field.
New Year, New Opportunities – NASH News
🎉Happy New Year! 🎉 We hope you had time to rest and refresh.
As we step into 2024, we’re excited to continue to bring the latest information and tackle the challenges and opportunities that lie ahead in the field of fatty liver disease. The beginning of the year signals a fresh start, filled with renewed energy and the promise of new opportunities.
Building up to Rare Liver Diseases Month
🎉Happy New Year! 🎉 We hope you had time to rest and refresh.
As we step into 2024, we’re excited to continue to bring the latest information and tackle the challenges and opportunities that lie ahead in the pediatric and rare liver diseases field.
Doctors and Experts around the World Call for Urgent Action to Prevent Liver Health Crisis
(Washington, D.C., December 11, 2023) – Global Liver Institute (GLI), the premier patient-led liver health nonprofit operating globally, released the second edition of its “Global State of Liver Health” report, now including 22 countries covering every region of the world. Following the impetus of the Liver Health is Public Health initiative, international experts drew attention to pressing opportunities for their respective governments to prioritize and improve liver health.
Congress passes Continuing Resolution to extend federal funding into the new year, addresses some health care priorities
Congress temporarily averted a government shutdown through the passage of a Continuing Resolution (CR) for funding the government into early 2024, specifically through February 2, 2024.
Biliary Atresia Patient Registry Launched by BARE Inc!
Chemomab Therapeutics has earned FDA fast track designation for its monoclonal antibody targeting primary sclerosing cholangitis (PSC).